I88 Stock Overview

Provides medical supplies, devices, and equipment, and related solutions that support patient care. More details

I88 fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	4/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 2.7% below our estimate of its fair value

Earnings are forecast to grow 24.42% per year

Earnings grew by 57.8% over the past year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Asker Healthcare Group AB Competitors

Price History & Performance

Summary of share price highs, lows and changes for Asker Healthcare Group
Historical stock prices
Current Share Price	SEK 7.17
52 Week High	SEK 7.98
52 Week Low	SEK 6.53
Beta	0
1 Month Change	9.80%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-5.66%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	I88	DE Medical Equipment	DE Market
7D	0%	1.2%	0.5%
1Y	n/a	-9.0%	14.4%

Return vs Industry: Insufficient data to determine how I88 performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how I88 performed against the German Market.

Price Volatility

Is I88's price volatile compared to industry and market?
I88 volatility
I88 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.4%
Market Average Movement	6.5%
10% most volatile stocks in DE Market	12.8%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: I88's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine I88's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2018	4,238	Johan Falk	www.asker.com

Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products for beauty clinics; defibrillators and wound care products; and health-related protection and trauma products for emergency care, police service, and military.

Asker Healthcare Group AB Fundamentals Summary

How do Asker Healthcare Group's earnings and revenue compare to its market cap?
I88 fundamental statistics
Market cap	€3.41b
Earnings (TTM)	€34.99m
Revenue (TTM)	€1.43b

97.4x

P/E Ratio

2.4x

P/S Ratio

Is I88 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
I88 income statement (TTM)
Revenue	SEK 15.57b
Cost of Revenue	SEK 9.40b
Gross Profit	SEK 6.17b
Other Expenses	SEK 5.79b
Earnings	SEK 382.00m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Jul 22, 2025

Earnings per share (EPS)	1.00
Gross Margin	39.64%
Net Profit Margin	2.45%
Debt/Equity Ratio	53.2%

How did I88 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/19 16:01
End of Day Share Price	2025/04/25 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Asker Healthcare Group AB is covered by 3 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Christoph Blieffert	BNP Paribas Exane
null null	Danske Bank
Carl Ragnerstam	Nordea Markets